To further investigate the potential synergistic benefits of Chrysin@mPDA + PTT treatment for breast cancer, we conducted an analysis of the subpopulations of CD3+CD4+ helper and CD3+CD8+ cytotoxic T cells. This evidence concerns the gene CD8A and breast carcinoma.